Riskpilot← Back to searchSign inGet full accessManubrium AB
ABActiveOrg 5591293096Östratornsvägen 45Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20171 employees
Revenue 2025
SEK 626K
-3% vs 2024
EBITDA margin
65.9%
-18% vs 2024
Equity ratio
47.1%
Financial strength
Net profit 2025
SEK 251K
-17% vs 2024
| Revenue | SEK 626K | -3% |
| EBITDA | SEK 412K | -18% |
| Net profit | SEK 251K | -17% |
| Total assets | SEK 849K | +27% |
| Equity | SEK 400K | +13% |
| Employees | 1 | — |
Legal name
Manubrium AB
Org number
5591293096
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård, konsultverksamhet och utbildning inom hälso- och sjukvård samt skola och utbildningsväsende så som översättning och språkgranskning. Forskning och utveckling inom hälso- och sjukvård. Tillverkning av och handel med medicinskteknisk utrustning. Handel med värdepapper, fastigheter och lös egendom så som antikviteter, möbler och konstföremål, sistnämnda nätbaserat. Med ovannämnda verksamhetsgrenar förenlig verksamhet.
Address
Östratornsvägen 45
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 153 | 426 | 416 | 646 | 626 |
| Staff expenses | — | −12 | −11 | −26 | −14 |
| EBITDA | 77 | 330 | 304 | 505 | 412 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 77 | 330 | 304 | 505 | 412 |
| Net financials | — | −0 | 1 | 1 | 12 |
| Profit before tax | 190 | 285 | 248 | 380 | 317 |
| Tax | −42 | −59 | −52 | −79 | −66 |
| Net profit | 148 | 226 | 196 | 301 | 251 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 225 | 454 | 429 | 671 | 849 |
| Equity | 199 | 325 | 247 | 353 | 400 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 26 | 85 | 80 | 89 | 113 |
| Total debt | 26 | 85 | 80 | 89 | 113 |
EBITDA margin
65.9%
This company
15.8%
Market median
+317% vs market
20212025
Equity ratio
47.1%
This company
38.2%
Market median
+23% vs market
20212025
Return on equity
62.8%
This company
18.4%
Market median
+241% vs market
20212025
Net profit margin
40.1%
This company
8.1%
Market median
+395% vs market
20212025
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
20212025
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Manubrium AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Emilia Persson Mörk | Deputy Board Member | 0 companies |
| Jan Persson | Board of Directors | 0 companies |